The most innovative drugs from cancer expo
This year's American Society for Clinical Oncology (ASCO) conference is over and as 45,000 scientists head home, DrugResearcher.com looks at some of the most innovative drugs that were on show.
Archives for June 10, 2007
Histological studies validate Rexin-G as targeted gene therapy for cancer
Histological evidence of tumour destruction has confirmed the promise of Epeius Biotechnologies' Rexin-G as an effective targeted gene therapy platform for metastatic cancer.
New triptorelin formulation Phase III cancelled
Ipsen has cancelled its Phase III trial of its sustained-release formulation of triptorelin while it attempts to fine-tune the manufacturing process of the hormone therapy drug.
Agilent reduces the noise in proteomics experiments
Agilent has launched a new tool that removes the 14 most abundant proteins found in blood plasma and serum to speed up the discovery and identification of low-abundance proteins and biomarkers.
Genzyme anticipates demand for thymoglobulin with new plant
Genzyme is expanding its manufacturing capabilities of thymoglobulin in France as it moves to meet the growing demand and future potential of the rabbit serum derivative.
Rexam swoops to O-I rescue
Major packaging player Rexam this morning announced that it will be scooping up the plastics business of beleaguered firm Owens-Illinois in a deal worth almost $2bn (€1.5bn).